To the Editor – Cardiac resynchronization therapy in coronary sinus atresia delivered using leadless endocardial pacing

نویسندگان

  • Berry M. van Gelder
  • Frank A. Bracke
چکیده

We read with great interest the report by Thomas et al describing the use of leadless left ventricular (LV) endocardial pacing in a patient with coronary sinus (CS) atresia. The technique they used was highly sophisticated but necessitated, besides implantation of the LV receiver-electrode, an ultrasound source for energy transmission and a separate battery pack for the ultrasound source. In our 17-year experience with cardiac resynchronization therapy, we have encountered CS ostial atresia in 4 patients. In the first patient we performed a left coronary artery angiogram to visualize the venous phase and the anatomy of the CS. This angiogram revealed a coronary venous system but with runoff in an upward direction toward the pectoral area. Subsequent contrast injection into the subclavian vein showed a persistent left superior vena cava (PLSVC) that gave access to the CS. It is therefore our opinion that if the CS cannot be intubated from the right atrium, a contrast injection in the proximal subclavian vein can elucidate the presence of a PLSVC; flow of contrast from the PLSVC toward the subclavian vein confirms the atresia of the CS. CS anatomy can be visualized by a selective angiogram and the decision can be made to proceed to a CS implant or to use an alternative implantation as described by Thomas et al. In our experience so far, all 4 patients had a successful CS lead implantation via the PLSVC with standard equipment and a more complicated approach could be avoided. Two of our patients have been described in case reports.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cardiac resynchronization therapy in coronary sinus atresia delivered using leadless endocardial pacing

Introduction Cardiac resynchronization therapy (CRT) has revolutionized the treatment of advanced heart failure. However, effective placement of a left ventricular (LV) pacing lead via the coronary venous system is subject to anatomical constraints. We present the case of a 78-year-old man with a history of dilated cardiomyopathy and severe LV impairment. It was not possible to implant a lead i...

متن کامل

Reply to the Editor – Regarding Cardiac Resynchronization Therapy in Coronary Sinus Atresia Delivered Using Leadless Endocardial Pacing

We thank Drs van Gelder and Bracke for their response to our paper. Their experience of 4 such cases of coronary sinus (CS) atresia during cardiac resynchronization therapy implantation emphasizes the strong association between this rare anomaly and the presence of a persistent left superior vena cava (PLSVC). They also make an important learning point about the ability of combining subclavian ...

متن کامل

Development of a technique for left ventricular endocardial pacing via puncture of the interventricular septum.

BACKGROUND Left ventricular (LV) pacing through the coronary sinus is the standard approach for cardiac resynchronization therapy. When this route is unavailable, the alternatives have major limitations. LV endocardial pacing through the interventriuclar septum may offer a simpler solution. We describe an initial case series to demonstrate technical feasibility and to describe our refinement of...

متن کامل

Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathy.

OBJECTIVES We sought to investigate the impact of left ventricular (LV) pacing site on mechanical response to cardiac resynchronization therapy (CRT) in patients with ischemic cardiomyopathy (ICM). BACKGROUND CRT reduces morbidity and mortality in patients with dyssynchronous LV failure; however, variability in response, particularly in ICM patients, poses ongoing challenges. Endocardial bive...

متن کامل

State of the art of leadless pacing.

Despite undisputable benefits, conventional pacemaker therapy is associated with specific complications related to the subcutaneous device and the transvenous leads. Recently, two miniaturized leadless pacemakers, Nanostim™ (St. Jude Medical) and Micra™ (Medtronic), which can be completely implanted inside the right ventricle using steerable delivery systems, entered clinical application. The W...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 3  شماره 

صفحات  -

تاریخ انتشار 2017